跳至主要内容
临床试验/NCT03973710
NCT03973710暂停不适用

Role of Probiotics in the Prevention of Hypertension

Sun Yat-sen University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
40
试验地点
1
主要终点
changes of systolic blood pressure

研究概览

简要总结

Dysbiosis of gut microbiota has been reported to be involved in the development and progression of hypertension in both humans and animal models. Probiotics have been reported to have ameliorative effects in murine models. However, whether probiotics could help alleviate hypertension in adults remain obscure.

详细描述

Probiotics are live microorganisms that have been associated with multiple health benefits. However, its protective role in adults has long been controversial. This study aims to examine the effect of 12-week probiotics supplementation on the prevention of hypertension in Chinese adults. By understanding the mechanisms by which probiotics exert this beneficial effects, we can better control the rising prevalence of hypertension, which is a major risk factor for cardiovascular diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Participants, investigators and care providers at the scene are all blinded to the allocation of treatment group. Data collected will be analyzed by another investigator who is blinded to the study design.

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible subjects include men and women 18 to 75 years of age with pre-hypertension who has a systemic blood between 120 and 139 mmHg and/ or a diastolic blood pressure between 80 and 80 mmHg;
  • Absence of any diet, dietary supplement and medications that might interfere with blood pressure and gut microbiota, especially antibiotics and probiotics.

排除标准

  • Any other systemic, metabolic and cardiovascular or cerebrovascular diseases;
  • Type 1 diabetes, type 2 diabetes treated with insulin or other medications;
  • Acute illness or current evidence of acute or chronic inflammatory or infective diseases;
  • Participation in any diet or lifestyle program more than 2 times per week in the latest 3 months prior to recruitment;
  • Mental illness rendering them unable to understand the nature, scope, and possible consequences of the study.

结局指标

主要结局

changes of systolic blood pressure

时间窗: baseline, 4 weeks, 8 weeks and 12 weeks

changes of systolic blood pressure

changes of gut microbiota

时间窗: baseline, 4 weeks, 8 weeks and 12 weeks

changes of gut microbiota by metagenomics

changes of diastolic blood pressure

时间窗: baseline, 4 weeks, 8 weeks and 12 weeks

changes of diastolic blood pressure

次要结局

  • changes of pulse wave velocity(baseline and after 12-week intervention)
  • changes of ankle brachial index(baseline and after 12-week intervention)
  • changes of microbial metabolite(baseline and after 12-week intervention)

研究者

发起方
Sun Yat-sen University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Min Xia

Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验